Showing results (121-130 of 157) with videos related to

Sort By:
Pageof 16
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 19, 2022
3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohortO Godin, B Pignon, A Szoke, et al.
Journal of Affective Disorders|November 15, 2018
Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohortG Fond, O Godin, F Schürhoff, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 16, 2018
Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohortG Fond, E Bulzacka, M Boucekine, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 25, 2022
Early-life factors associated with increased risk of disability pension in the national real-world schizophrenia FACE-SZ cohort studyG Fond, J Dubreucq, P L Sunhary de Verville, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 27, 2017
Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohortG Fond, F Berna, M Andrianarisoa, et al.
Schizophrenia Research|August 11, 2015
Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohortO Godin, M Leboyer, A Gaman, et al.
Pageof 16